HomeTRYP • CNSX
add
Tryp Therapeutics Inc
Previous close
$0.060
Year range
$0.010 - $0.11
Market cap
5.73M CAD
Avg Volume
87.26K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Nov 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 950.96K | -41.17% |
Net income | -1.16M | 28.99% |
Net profit margin | — | — |
Earnings per share | -0.01 | 50.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Nov 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.06M | 147.53% |
Total assets | 2.35M | 86.51% |
Total liabilities | 7.25M | 362.47% |
Total equity | -4.89M | — |
Shares outstanding | 96.42M | — |
Price to book | -1.20 | — |
Return on assets | -158.20% | — |
Return on capital | 309.28% | — |
Cash Flow
Net change in cash
(CAD) | Nov 2023info | Y/Y change |
---|---|---|
Net income | -1.16M | 28.99% |
Cash from operations | -968.99K | 0.17% |
Cash from investing | — | — |
Cash from financing | 2.67M | — |
Net change in cash | 1.70M | 274.98% |
Free cash flow | -575.91K | -63.56% |
About
Founded
2019
Headquarters
Website